Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo — Buffalo, New York

Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo is a clinical research site located in Buffalo, New York, United States 14203.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Multiple Sclerosis.

Sponsors: Universiteit Leiden.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo?

Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo conducted?

Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo has 1 clinical trials on record, with 1 currently active. Their work covers Multiple Sclerosis.

Is Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo accredited by Crixeo Health?

Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.